NCT06814548View on ClinicalTrials.gov

Immune Checkpoint Inhibitors (ICIs) Retreatment in Second-line Treatment of Advanced Gastric Cancer: a Retrospective, Real-world Study

Not yet recruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

February 10, 2025

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions

Gastric Cancer, Gastroesophageal Junction CancerImmune Checkpoint Inhibitors (ICIs)Second-lineRetreatment

Interventions

OTHER

ICIs(Immune checkpoint inhibitors)

N

All Listed Sponsors

lead

Yongxu Jia

OTHER